CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory Distress Syndrome (ARDS) and/or Multiple Organ Dysfunction Syndrome (MODS), including those infected with SARS-CoV-2 (COVID-19).

Biotechnology

CMTx Biotech

Joseph Scaduto

Sharon Nachman

Joann Wilson

James Keane

Christopher Czura

Lorne Golub

Sonny Granger

The Advisory Team at CMTx Biotech provides strategic guidance and expert insights to support the development and clinical progression of the company's novel treatments for sepsis-related conditions. Leveraging their diverse expertise, the advisors help to navigate regulatory pathways, optimize trial designs, and foster partnerships to accelerate the delivery of life-saving therapies.

Advisory Team

Leadership Team

Advisory Team

About

Team members

Other teams at CMTx Biotech

Leadership Team